Select Medical Holdings Corp. Agrees to Be Acquired by Insider-Led Consortium
SEM sits 29% above its 52-week low of $11.65.
Summary
Select Medical Holdings Corporation has announced it will be acquired by a consortium led by its Executive Chairman, Robert A. Ortenzio, Martin F. Jackson, and WCAS. This definitive agreement follows a series of recent disclosures, including a non-binding take-private offer from the same group detailed in an 8-K on February 19th and a refined offer in a Schedule 13D/A on February 23rd. The transition from a non-binding offer to a confirmed acquisition agreement is a highly material development, providing clarity on the company's future and typically causing the stock price to move towards the acquisition price. Traders will now focus on the specific financial terms of the deal and the expected timeline for closing.
At the time of this announcement, SEM was trading at $15.00 on NYSE in the Life Sciences sector, with a market capitalization of approximately $1.9B. The 52-week trading range was $11.65 to $18.61. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Dow Jones Newswires.